Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,725 | 6,608 | 3,681 | 2,765 | 1,502 |
| Cost of Goods | N/A | 66 | 5 | 39 | 36 |
| Gross Profit | 1,725 | 6,542 | 3,676 | 2,726 | 1,466 |
| Operating Expenses | 9,318 | 13,156 | 7,467 | 22,545 | 8,007 |
| Operating Income | -7,593 | -6,548 | -3,786 | -19,780 | -6,505 |
| Other Income | 2,804 | 2,160 | -25,966 | -10,584 | 2,362 |
| Pre-tax Income | -4,789 | -4,388 | -29,752 | -30,364 | -4,143 |
| Net Income Continuous | -4,789 | 892 | -29,752 | -30,364 | -4,143 |
| Minority Interests | 23 | 41 | 29 | 100 | -4 |
| Net Income | $-4,812 | $851 | $-29,781 | $-30,464 | $-4,139 |
| EPS Basic Total Ops | -0.02 | 0.00 | -0.13 | -0.13 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | 0.01 | -0.13 | -0.13 | -0.02 |
| EPS Diluted Total Ops | -0.03 | 0.00 | -0.13 | -0.13 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | 0.01 | -0.13 | -0.13 | -0.02 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.00 | -0.13 | -0.01 | -0.02 |
| EBITDA(a) | $-7,405 | $-6,379 | $-3,561 | $-4,857 | $-6,341 |